Transcobalamin II receptor imaging via radiolabeled diethylene-triaminepentaacetate cobalamin analogs

Journal of Nuclear Medicine

Volumn 38, Issue 5, 1997, Pages 717-723

  Collins, Douglas A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Receptor imaging; Tumor seeking agent; Vitamin b12

Indexed keywords

COBALAMIN DERIVATIVE; CYANOCOBALAMIN; DRUG RECEPTOR; PENTETATE INDIUM IN 113M; PENTETIC ACID DERIVATIVE; TRANSCOBALAMIN II;

ANIMAL MODEL; ARTICLE; BINDING COMPETITION; CANCER LOCALIZATION; CANCER SCINTISCANNING; CONTROLLED STUDY; DNA REPLICATION; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION;

ANIMALS; COBAMIDES; FEMALE; INDIUM RADIOISOTOPES; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PENTETIC ACID; RECEPTORS, CELL SURFACE; SARCOMA, EXPERIMENTAL; SWINE; TECHNETIUM; TISSUE DISTRIBUTION; TRANSCOBALAMINS; VITAMIN B 12;

EID: 0031000306     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ishiwata K, Takahashi T, Iwata R, et al. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model. Nucl Med Biol 1992; 19:611-618.
2. Schmall B, Conti PS, Schaeffer DJ, Kleinert EL. Tumor and organ biochemical profiles determined in vivo following uptake of a combination of radiolabeled substates: potential applications for PET. Am J Physiol Imaging 1992;7:2-11.
3. Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, Ido T. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C] methionine, [6-3H]thymidine, and gallium-67. J Nucl Med 1991;32:2118-2123.
4. Shields AF, Lim K, Grierson J, Link J, Krohn KA. Utilization of labeled thymidine in DNA synthesis: studies for PET. J Nucl Med 1990;31:337-342.
5. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methione and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993;34:773-779.
6. Sato K, Kameyama M, Ishiwata K, Katakura R, Yoshimoto T. Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers. J Neurooncol 1992; 14:81-89.
7. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue. A microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-492.
8. Goethals P, van Eijkeren M, Lodewyck W, Dams R. Measurement of [methyl-carbon-11] thymidine and its metabolites in head and neck tumors. J Nucl Med 1995;36:880-882.
9. Ryel EM, Meyer LM, Gams RA. Uptake and subcellular distribution of Vitamin B12 in mouse L1210 leukemic lymphoblasts. Blood 1974;44:427-432.
10. Hall CA, Colligan PD. The function of cellular transcobalamin II in cultured human cells. Exp Cell Res 1989;183:159-167.
11. Gimsing P, Hippe E. Cobalamin-dependent metabolism in chronic myelogenous leukemia determined by deoxyuridine suppression test and the formiminoglutamic acid and methylmalonate excretion in urine. Am J Hematol 1995;49:12I-130.
12. Begley JA, Colligan PD, Chu RC. Synthesis and secretion of transcobalamin II by cultured astrocytes derived from human brain tissue. J Neural Sei 1994; 122:57-60.
13. Lindemans J, Kroes ACM, van Geel J, van Kapel J, Schoester M, Abels J. Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction. Exp Cell Res 1989; 184:449-460.
14. Amagasaki T, Green R, Jacobsen DW. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells. Blood 1990;76:1380-1386.
15. Hall CA, Green-Colligan PD, Begley JA. The metabolism of cobalamin bound to transcobalamin II and to glycoproteins that bind Cbl in HepG2 cells (human hepatoma). J Cell Physiol 1985;124:507-515.
16. Cooper BA, Paranchyma W. Selective uptake of specifically bound cobalt-58 vitamin B12 by human and mouse tumor cells. Nature 1961;191:393-395.
17. Flodh H. Accumulation of labelled vitamin B-12 in some transplanted tumors. Acta Radiol Suppl 1968;284:55-60.
18. Blomquist L, Flodh H, Ullberg S. Uptake of labelled vitamin B-12 and 4-iosophenyl alanine in some tumours of mice. Experientia 1969;25:294-296.
19. Cooperman JM. Distribution of radioactive and nonradioactive vitamin B-12 in normal and malignant tissues of an infant with neuroblastoma. Cancer Res 1972;32:167-172.
20. Babior BM. Cobalamin: biochemistry and pathophysiology. New York: Wiley & Sons; 1975:289-333.
21. Eckelman WC, Karesh SM, Reba RC. New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. J Pharm Sei 1975;64: 704-706.
22. Kikugawa K, Ichino M. Tetrahedron Lett 1971:87-90.
23. Hogenkamp HPC. Chemical synthesis and properties of analog of adenosylcobalamin. Biochemistry 1974; 13:2736 -2740.
24. Anton DL, Hogenkamp HPC, Walker TE, Matwivoff NA. Carbon-13 nuclear magnetic studies of the monocarboxylic acids of cyanocobalamin. Assignments of the b-, d-, and e-monocarboxylic acids. J Am Chem Soc 1980; 102:2215-2219.
25. Yamada RH, Hogenkamp HPC. The synthesis of a 5'-deoxyadenosylcobalarninagarose adsorbent and its utility in the purification of ribonucleotide reductase. J Biol Chem 1972;247:6266-6270.
26. Dolphin D. Preparation of the reduced forms of vitamin BI2 coenzyme containing a cobalt-carbon bond. Methods Enzymol 1971:18;34-52.
27. Fairbanks VF, Lennon VA, Kokmen E, Howard FM. Tests for pernicious anemia: serum intrinsic factor blocking antibody. Mayo Clin Proc 1983;58:203-204.
28. Diagnostic Products Corporation. Product Insert. Intrinsic Factor Blocking Antibody [57Co] Radioassay.
29. Grossowicz D, Sulitzeanu D, Merzbach D. Isotopic determination of vitamin B,2 binding capacity and concentration. Proc Soc Exp Biol Med 1962;109:604-608.
30. Gottlieb C, Lau K-S, Wasserman LR, Herbert V. Rapid charcoal assay for intrinsic factor (IF), gastric juice unsaturated B12 binding capacity, antibody to IF, and serum unsaturated B12 binding capacity. Blood 1965;25:875-884.
31. Rosenblum C, RL Davis, BF Chow. Comparative absorption of vitamin B,2 analogues by normal humans. III. 5,6-Dichlorobenzimidazole, 5,6-Desdimethylbenzimidazole and 5-Hydroxybenzimidazole analogues. Proc Soc Exp Biol Med 1957;95:30-32.
32. Rosenblum C, Woodbury DT, Gilbert JP, Okuda K, Chow BF. Comparative absorption of vitamin B12 analogues by normal humans. I. Chlorocobalamin vs. cyanocobalamin. Proc Soc Exp Biol Med 1955;89:63-65.
33. Rosenblum C, Yamamato RS, Wood R, Woodbury DT, Okuda K, Chow BF. Comparative absorption of vitamin B12 analogues by normal humans. II. Chloro-, sulfato-, nitro-, and thiocyanoto- vs. cyanocobalamin. Proc Soc Exp Biol Med 1956;91:364-366.
34. Cooperman JM, Luhby AL, Teller DN, Marley JF. Distribution of radioactive and nonradioactive vitamin B,2 in the dog. J Biol Chem 1960;235:191-194.
35. Rappazzo ME, Salmi HA, Hall CA. The content of Vitamin B12 in adult and foetal tissue: a comparative study. Br J Haematol 1970;18:425-433.
36. Rigby CC, Bodian M. Experimental study of the relationship between vitamin B12 and two animal tumour systems. Br J Cancer 1963:17:90-99.
37. Warnock SH, Collins DA, Morton KA. Comparison of tumor uptake and nuclear medicine images of gallium-67, thallium-201, and cobalt-57-vitamin B-12 in sarcomabearing mice. Clin Res 1992;40:7A.
38. Wooley KE, Collins DA, Morton KA. Uptake of Co-57-vitamin B-12 by murine tumors of many histologie types. Clin Res 1993;41:73.
39. McAfee JG, Gagne G, Atkins HL, et al. Biological distribution and excretion of DTPA labeled with Tc-99m and In-111. J Nucl Med 1979;20:1273-1278.
40. Stevens E, Rosoff B, Weiner M, Spencer H. Metabolism of the chelating agent diemylenetriamine pentaacetic acid (I4CDTPA) in man. Proc Soc Exp Biol Med 1962;111:235-238.